Avanos Medical Inc. (AVNS)
NYSE: AVNS
· Real-Time Price · USD
11.20
0.24 (2.19%)
At close: Aug 15, 2025, 3:59 PM
11.22
0.22%
After-hours: Aug 15, 2025, 06:00 PM EDT
Avanos Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -76.8M | 6.6M | -397.3M | 4.3M | 4.3M | 500K | 11M | -3.7M | -68.1M | -500K | 16.9M | 16.4M | 11.4M | 5.8M | 10M | -35.1M | 37.9M | -7.6M |
Depreciation & Amortization | 10M | 9.6M | 11.1M | 11.7M | 11.3M | 11.4M | 11.5M | 11M | 11.5M | 12.1M | 13.4M | 11.6M | 11.6M | 11.1M | 9.5M | 9.6M | 9.5M | 9.7M |
Stock-Based Compensation | 4.1M | 3.8M | 3.8M | 2.6M | 3.8M | 3.6M | 4M | 3.9M | 3.9M | 4M | 4M | 4.1M | 4M | 3.8M | 3M | 3.5M | 3.6M | 3.1M |
Other Working Capital | -5.3M | -14.5M | -500K | 10.7M | 23.7M | -28.2M | -25.3M | 17.2M | -7.7M | -29M | 10.9M | 13.1M | 400K | -28.5M | 14.1M | 28.7M | -2.8M | -1.5M |
Other Non-Cash Items | 76.3M | 300K | 395.3M | 700K | 36.7M | 19.5M | -3.8M | 1.2M | 63.5M | -3.1M | 700K | 400K | 27.7M | 16M | 3.1M | -4.2M | 4.8M | 100K |
Deferred Income Tax | n/a | n/a | n/a | n/a | 9.6M | n/a | -6.6M | -3.9M | n/a | n/a | 300K | n/a | 100K | -400K | 12M | 37.3M | -46.7M | -5.9M |
Change in Working Capital | -6.8M | 5.4M | 45M | 3.7M | 10.9M | -22.4M | -3.4M | 20.6M | -13.4M | -19.3M | -1.6M | -4.1M | -100K | -18.5M | 14.6M | 7.9M | 6.2M | -2.7M |
Operating Cash Flow | 6.8M | 25.7M | 57.9M | 23M | 27.8M | -8M | 12.7M | 29.1M | -2.6M | -6.8M | 33.7M | 28.4M | 27M | 1.8M | 52.2M | 23.2M | 15.3M | -3.3M |
Capital Expenditures | -11M | -6.7M | -4.8M | -3M | -5.9M | -4.1M | -5.9M | -3.9M | -4M | -4M | -4.9M | -5.3M | -4.1M | -5M | -4.8M | -4.8M | -5.8M | -5.7M |
Cash Acquisitions | -2.2M | -2.4M | n/a | n/a | n/a | 2.1M | 86.9M | -45M | -2.5M | n/a | -116.1M | 600K | n/a | -116.7M | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -2.8M | -9M | -5.9M | 2.1M | 89M | -45M | -2.5M | n/a | 116.1M | 600K | n/a | -116.7M | -7.9M | n/a | n/a | n/a |
Investing Cash Flow | -13.2M | -9.1M | -7.6M | -12M | -5.9M | -2M | 81M | -48.9M | -6.5M | -4M | -4.9M | -4.7M | -4.1M | -121.7M | -4.8M | -4.8M | -5.8M | -5.7M |
Debt Repayment | -2.4M | -27.3M | -27.3M | -13.2M | -1.5M | 8.4M | -96.6M | 55M | -1.5M | -21.6M | -21.6M | n/a | n/a | 125M | -15M | -20M | -10M | -5M |
Common Stock Repurchased | -800K | -2.2M | -100K | -100K | -3.5M | -9.1M | -6.2M | -9.2M | -2.6M | -1.1M | -400K | -11M | -14.7M | -19.4M | -10.9M | -100K | -500K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.4M | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 400K | n/a | -2.7M | n/a | n/a | -11.7M | 900K | 0.00 | 600K | 100K | 800K | -2.2M | 100K | 100K | 900K | 400K | 4.8M |
Financial Cash Flow | -3.2M | -29.1M | -27.4M | -16M | -5M | -700K | -114.7M | 46.7M | -4.1M | -22.1M | -21.9M | -10.2M | -16.9M | 105.7M | -25.8M | -19.2M | -10.1M | -200K |
Net Cash Flow | -6.7M | -10.7M | 18.7M | -3.2M | 16.4M | -11.9M | -19.4M | 25.3M | -13.9M | -32M | 10.7M | 10.5M | 2.2M | -14.2M | 20.7M | -2.1M | -200K | -11.4M |
Free Cash Flow | -4.2M | 19M | 53.1M | 20M | 21.9M | -12.1M | 6.8M | 25.2M | -6.6M | -10.8M | 28.8M | 23.1M | 22.9M | -3.2M | 47.4M | 18.4M | 9.5M | -9M |